ZimVie (ZimVie) ROCE % : 8.07% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is ZimVie ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. ZimVie's annualized ROCE % for the quarter that ended in Dec. 2023 was 8.07%.

ZimVie ROCE % Historical Data

The historical data trend for ZimVie's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZimVie ROCE % Chart

ZimVie Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-1.44

-12.16

1.25

-2.85

-2.49

ZimVie Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial											7.40	-4.84	-6.15	-4.80	8.07

ZimVie ROCE % Calculation

ZimVie's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-30.613	/	( ( (1642.056 - 217.309)	+	(1205.345 - 173.614) )	/ 2 )
	=	-30.613	/	( (1424.747	+	1031.731)	/ 2 )
	=	-30.613	/	1228.239
	=	-2.49 %

ZimVie's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	95.532	/	( ( (1507.921 - 171.217)	+	(1205.345 - 173.614) )	/ 2 )
	=	95.532	/	( ( 1336.704	+	1031.731 )	/ 2 )
	=	95.532	/	1184.2175
	=	8.07 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

ZimVie (NAS:ZIMV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

ZimVie ROCE % Related Terms

Thank you for viewing the detailed overview of ZimVie's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

ZimVie (ZimVie) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ZimVie Inc (NAS:ZIMV) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

O23:Germany

Address

10225 Westmoor Drive, Westminster, CO, USA, 80021

Website

https://www.zimvie.com

ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.

Executives

Camber Capital Management Lp	10 percent owner	101 HUNTINGTON AVENUE, SUITE 2101, BOSTON MA 02199
Sally Crawford	director	C/O HOLOGIC, INC., BEDFORD MA 01730
Vafa Jamali	director, officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Richard Heppenstall	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Zimmer Biomet Holdings, Inc.	10 percent owner	345 EAST MAIN STREET, WARSAW IN 46580
Richard Kuntz	director	MEDTRONIC, INC., 710 MEDTRONIC PWKY MS LC 310, MINNEAPOLIS MN 55432
Vinit K Asar	director	10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Karen Matusinec	director	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David P King	director	PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Rebecca Ann Whitney	officer: See Remarks	10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David John Harmon	officer: See Remarks	10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Indraneel Kanaglekar	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Heather Kidwell	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Sandra Schneider	officer: Chief Accounting Officer	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021